What does Dr. Lise Cornelis - Huisarts do?

Dr. Lise Cornelis - Huisarts is a general practice in Gent. Private Limited, started on 25 April 2019, 1 establishment.

What is the address of Dr. Lise Cornelis - Huisarts?

The registered office of Dr. Lise Cornelis - Huisarts is located at Emanuel Hielstraat 64, 9050 Gent.

Is Dr. Lise Cornelis - Huisarts still active?

Yes. According to the CBE (2 November 2026) Dr. Lise Cornelis - Huisarts is active, legal situation “Normale toestand”, started on 25 April 2019.

Is Dr. Lise Cornelis - Huisarts registered on Peppol?

Yes, Dr. Lise Cornelis - Huisarts is registered on the Peppol network with ID 0208:0725711042.

What is the enterprise number of Dr. Lise Cornelis - Huisarts?

The enterprise number of Dr. Lise Cornelis - Huisarts is BE0725711042.

When was Dr. Lise Cornelis - Huisarts founded?

Dr. Lise Cornelis - Huisarts was founded on 25 April 2019.

Who are the directors of Dr. Lise Cornelis - Huisarts?

According to the 2025 annual accounts, the directors of Dr. Lise Cornelis - Huisarts are: Lise Cornelis.

Is Dr. Lise Cornelis - Huisarts a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 25 April 2019; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Lise Cornelis - Huisarts make in 2025?

Dr. Lise Cornelis - Huisarts posted a profit after taxes of € 30,656 in financial year 2025.

What is the revenue of Dr. Lise Cornelis - Huisarts?

As a small company, Dr. Lise Cornelis - Huisarts is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 27,111.

Dr. Lise Cornelis - Huisarts (Private Limited) - Gent

Dossier Dr. Lise Cornelis - Huisarts, printed on 2 November 2026 from databakkes.be/en/0725711042/dr-lise-cornelis-huisarts. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Lise Cornelis - Huisarts from Gent, company number BE0725711042, closed financial year 2025 with a result of € 30,656 after tax. For that financial year Dr. Lise Cornelis - Huisarts recorded a gross margin of € 27,111 and equity of € 49,727. Compared with financial year 2024, the result moved from € 147 to € 30,656. Profitable, and profit is growing. The buffer shrank hard: equity is 68 % below last year. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 22, 2026.

What it is worth Shrank hard

€ 49,727

▼ 68% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 30,656

▲ € 30,509 vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 39,994

▼ 57% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 136,100 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 36,648

▼ 22% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 21,467 Gross margin 2022: € 21,467 First fiscal year in the series	€ 24,732 Gross margin 2023: € 24,732 ▲ 15% vs 2022 (€ 21,467) Favourable step	€ 6,442 Gross margin 2024: € 6,442 ▼ 74% vs 2023 (€ 24,732) Unfavourable step	€ 27,111 Gross margin 2025: € 27,111 ▲ € 20,670 vs 2024 (€ 6,442) Favourable step	▲ € 20,670
Profit after taxes	€ 14,069 Profit after taxes 2022: € 14,069 First fiscal year in the series	€ 16,632 Profit after taxes 2023: € 16,632 ▲ 18% vs 2022 (€ 14,069) Favourable step	€ 147 Profit after taxes 2024: € 147 ▼ 99% vs 2023 (€ 16,632) Unfavourable step	€ 30,656 Profit after taxes 2025: € 30,656 ▲ € 30,509 vs 2024 (€ 147) Favourable step	▲ € 30,509
Equity	€ 139,226 Equity 2022: € 139,226 First fiscal year in the series	€ 155,025 Equity 2023: € 155,025 ▲ 11% vs 2022 (€ 139,226) Favourable step	€ 155,171 Equity 2024: € 155,171 Unchanged (€ 155,025) Favourable step	€ 49,727 Equity 2025: € 49,727 ▼ 68% vs 2024 (€ 155,171) Unfavourable step	▼ 68%
Total debts	€ 52,963 Total debts 2022: € 52,963 First fiscal year in the series	€ 47,158 Total debts 2023: € 47,158 ▼ 11% vs 2022 (€ 52,963) Favourable step	€ 48,011 Total debts 2024: € 48,011 ▲ 2% vs 2023 (€ 47,158) Unfavourable step	€ 41,645 Total debts 2025: € 41,645 ▼ 13% vs 2024 (€ 48,011) Favourable step	▼ 13%
Cash	€ 112,802 Cash 2022: € 112,802 First fiscal year in the series	€ 112,221 Cash 2023: € 112,221 ▼ 1% vs 2022 (€ 112,802) Unfavourable step	€ 92,812 Cash 2024: € 92,812 ▼ 17% vs 2023 (€ 112,221) Unfavourable step	€ 39,994 Cash 2025: € 39,994 ▼ 57% vs 2024 (€ 92,812) Unfavourable step	▼ 57%
Retained profit	€ 120,626 Retained profit 2022: € 120,626 First fiscal year in the series	€ 136,425 Retained profit 2023: € 136,425 ▲ 13% vs 2022 (€ 120,626) Favourable step	€ 136,571 Retained profit 2024: € 136,571 Unchanged (€ 136,425) Favourable step	€ 31,127 Retained profit 2025: € 31,127 ▼ 77% vs 2024 (€ 136,571) Unfavourable step	▼ 77%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 833 Dividend 2023: € 833 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 833) Unchanged	€ 136,100 Dividend 2025: € 136,100 Unchanged (€ 0) Unchanged
Balance sheet total	€ 192,189 Balance sheet total 2022: € 192,189 First fiscal year in the series	€ 202,183 Balance sheet total 2023: € 202,183 ▲ 5% vs 2022 (€ 192,189) Unchanged	€ 203,182 Balance sheet total 2024: € 203,182 Unchanged (€ 202,183) Unchanged	€ 91,373 Balance sheet total 2025: € 91,373 ▼ 55% vs 2024 (€ 203,182) Unchanged	▼ 55%

Key figures of Dr. Lise Cornelis - Huisarts, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Lise Cornelis - Huisarts?

What happened at Dr. Lise Cornelis - Huisarts in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 22, 2026 New annual accounts for financial year 2025: profit of € 30,656 (▲ € 30,509 vs 2024). Source: NBB ↗
Apr 25, 2019 New establishment in Merelbeke-Melle. KBO
2019 Lise Cornelis became a director. NBB
Apr 25, 2019 Start of the company according to the CBE. KBO

In short

From € 14,069 profit in 2022 to € 30,656 profit in 2025.

Paid € 17,154 in corporate taxes since 2022.

Best year ever: 2025, with € 30,656 profit.

Paid out € 136,933 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Lise Cornelis

Dr. Lise Cornelis - Huisarts

Behind Dr. Lise Cornelis - Huisarts is Lise Cornelis.

Directors

According to the 2025 annual accounts

Lise Cornelis

Director

since 2019

Establishments

Establishment units

Physical locations of this company

Registered office

Emanuel Hielstraat 64

9050 Gent

2.288.302.650

Florastraat 31

9820 Merelbeke-Melle

Active since 25 April 2019

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0725.711.042
VAT number: BE 0725.711.042
Registered office: Emanuel Hielstraat 64, 9050 Gent
Names & denominations: Dr. Lise Cornelis - Huisarts
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 25 April 2019
Peppol: Active · Active since 4 Sept 2025
Activities · NACE: Activiteiten van huisartspraktijken

View on CBE Public ↗ Annual accounts (NBB) ↗